Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients

• Published in: Liver transplantation Vol. 29; no. 1; pp. 91 - 102
• Main Authors: Morales Junior, Ronaldo, Telles, João Paulo, Kwiatkowski, Shaina Ying-Ching, Juodinis, Vanessa D'Amaro, de Souza, Daniela Carla, Santos, Silvia Regina Cavani Jorge
• Format: Journal Article
• Language: English
• Published: United States 01.01.2023
• Subjects: Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Antifungal Agents - pharmacokinetics; Antifungal Agents - therapeutic use; Humans; Liver; Liver Transplantation - adverse effects
• ISSN: 1527-6465; 1527-6473
• DOI: 10.1002/lt.26517

The liver plays a major role in drug metabolism. Liver transplantation impacts the intrinsic metabolic capability and extrahepatic mechanisms of drug disposition and elimination. Different levels of inflammation and oxidative stress during transplantation, the process of liver regeneration, and the characteristics of the graft alter the amount of functional hepatocytes and activity of liver enzymes. Binding of drugs to plasma proteins is affected by the hyperbilirubinemia status and abnormal synthesis of albumin and alpha-1-acid glycoproteins. Postoperative intensive care complications such as biliary, circulatory, and cardiac also impact drug distribution. Renally eliminated antimicrobials commonly present reduced clearance due to hepatorenal syndrome and the use of nephrotoxic immunosuppressants. In addition, liver transplantation recipients are particularly susceptible to multidrug-resistant infections due to frequent manipulation, multiple hospitalizations, invasive devices, and frequent use of empiric broad-spectrum therapy. The selection of appropriate anti-infective therapy must consider the pathophysiological changes after transplantation that impact the pharmacokinetics and pharmacodynamics of antibiotics and antifungal drugs.